An online educational module on the use of CDK4/6 inhibitors to treat advanced breast cancer was just released. This module is part of a larger educational curriculum on a novel, new approach to treat advanced breast cancer.
FOR IMMEDIATE RELEASE
Breast Cancer Educational Curriculum on the Use of CDK4/6 Inhibitors Launches with its First Online Activity
January 18, 2017 - Chester, CT -- With the integration of patient cases, scientific animation, interactive questions, and expert faculty presentations this new breast cancer educational activity offers a learning experience for practicing healthcare professionals that mimics a clinical experience. About 1 out of 8 women in the U.S. will develop invasive breast cancer over the course of their lifetime, and in 2017 it is estimated that 255,180 new cases of invasive breast cancer will be diagnosed in the U.S. It becomes imperative for oncology professionals to remain current on new, novel therapies for breast cancer. Titled ENDURE: Engagement with Novel Therapies and Decision Making Through Breast Cancer Education, this new online educational activity is designed to improve the treatment of patients with advanced breast cancer, with the ultimate goal of improving their outcomes.
Any healthcare professional who cares for patients with breast cancer is welcome to participate in this free interactive and informative activity online. Participants will see and hear breast cancer experts provide practical insights on the management of the disease. Participation is easy – to access the activity, simply visit one of two websites: https://learning.freecme.com/attendee/view_program.jsp?programCode=25921PmzqF8 or http://www.cmeuniversity.com/course/disclaimer/113855.
Linda Sutton, MD, P. Kelly Marcom, MD, and Richard S. Finn, MD are the expert faculty for this educational activity. Dr. Sutton is an Associate Professor of Medicine at the Duke University School of Medicine, and the Medical Director for the Duke Cancer Network. Dr. Marcom is an Associate Professor of Medicine at the Duke University School of Medicine and Director of the Duke Cancer Institute Breast Cancer Program. Dr. Finn is an Associate Professor of Medicine, Division of Hematology/Oncology at the Geffen School of Medicine at UCLA.
“ENDURE: Engagement with Novel Therapies and Decision Making Through Breast Cancer Education is intended for the practicing oncology professional and provides practical applications of the most current data on a new treatment option for patients with advanced breast cancer,” said Dr. Sutton.
This online activity is part of a larger breast cancer educational curriculum that includes symposia at the Miami Breast Cancer Conference, Oncology Nursing Society Annual Congress and the American Society of Clinical Oncology Annual Meeting. The curriculum also includes educational meetings held at Duke Cancer Network affiliated oncology centers, and a live webinar to be launched later in 2017. The symposium at the Miami Breast Cancer Conference is neither affiliated with nor endorsed by Physicians’ Education Resource®, LLC (PER®) or the Annual Miami Breast Cancer Conference®.
Along with the expert faculty, this educational activity is jointly provided by the Duke Cancer Network (https://affiliations.dukehealth.org/services/cancer-network) and Catamount Medical Education (http://www.catmeded.com/). The activity is supported by an independent educational grant from Pfizer Inc.
Contact Jennifer Green for more information at jgreencatmeded.com or call at 860.661.4164.
# # #